| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $242K | — | — |
| Cost of Revenue | $97K | — | — |
| R&D Expense | $1.4M | +44.8% | +133.9% |
| SG&A Expense | $2.8M | +2.4% | +16.6% |
| Operating Income | -$4.0M | -7.9% | -33.2% |
| Income Tax | $0 | — | — |
| Net Income | -$5.9M | +66.5% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.2M | +146.9% | +336.5% |
| Accounts Receivable | $239K | — | — |
| Current Assets | $11.9M | +160.3% | +191.0% |
| Total Assets | $15.0M | +210.0% | +236.1% |
| Current Liabilities | $40.6M | +0.3% | +100.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.4M | — | — |
| Investing Cash Flow | -$2.6M | — | — |
| Financing Cash Flow | $18.7M | — | — |
| -262.9% |
| EPS (Basic) | -$0.27 | +72.4% | -80.0% |
| $40.8M |
| +0.7% |
| +75.0% |
| Stockholders' Equity | -$25.8M | +27.7% | -36.8% |